Experiences with Recombinant Factor VIIa for the Prevention of Bleeding in Patients with Chronic Liver Disease Undergoing Percutaneous Liver Biopsies and Endoscopic Retrograde Cholangiopancreatography (ERCP)

Thromb Haemost 2001; 86(04): 1125-1126
DOI: 10.1055/s-0037-1616549

Letters to the Editor

Schattauer GmbH

Chomsri Kositchaiwat

¹Division of Gastroenterology and Tropical Medicine, Department of Medicine, Mahidol University, Bangkok, Thailand

,

Ampaiwan Chuansumrit

²Division of Hematology, Department of Paediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

References
1 Brophy MT, Fiore LD, Deykin D. Hemostasis. In: Hepatology. A textbook of liver disease. 3^rd ed. Zakim D, Boyer TD. eds. Pensylvania: W. B. Saunders Company; 1996: 706-7.
2 Bernstein DE, Jeffer L, Erhardtsen E, Reddy KR, Glazer S, Squiban P, Bech R, Hedner U, Schiff ER. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study. Gastroenterol 1997; 113: 1930-7.
3 Kalicinski P, Kaminski A, Drewniak T, Ismail H, Szymczak M, Markiewicz M, Lukasiewicz H. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplantation Proceedings 1999; 31: 378-9.